North American Imaging Agent Market size is predicted to cross USD 4.6 billion by 2028, according to a latest forecast report by Graphical Research.
Inventions in imaging procedures along with imaging agents, is one of the major aspects driving the business progression. Technological advancements as well as innovations offer effective, non-invasive, and convenient procedures that will increase the adoption rate of such procedures. Recently, in 2021, researchers introduced advanced imaging agents to track and accelerate the diagnosis method for the development of tumor leading to cancer. Also, in August 2021, GE Healthcare experimented clinical trials for the F18 Angio radioactive PET contrast agent. This imaging agent is intended for imaging angiogenesis. This agent detects formation of new blood vessels in the body during wound healing and growth of malignant tumor.
The iodinated contrast media segment accounted for USD 1.4 billion revenue in 2021. Iodinated contrast media is a type of intravenous radiocontrast that are administered to patients during the imaging procedure. It helps the physicians to visualize the vascular structures and organs during radiography operations such as X-rays and computed tomography (CT) scans. Iodinated contrast media are agents that contain iodin atoms used in compounded tomography (CT), radiography, angiography, and fluoroscopy. In addition, iodinated contrast media contains iodine that makes vascular system and organs clearly visible during radiography thus securing segmental expansion.
The cardiology segment crossed 987 million revenue in 2021, owing to increasing cases of cardiovascular diseases across the region. Contrast agents are commonly used in cardiology to detect irregularities or blockages in the arteries. It increases the imaging clarity of blood arteries and cardiac structures, allowing them to be seen more clearly. Few common cardiovascular diseases include coronary heart disease, strokes and peripheral arterial disease among others. These are mainly caused due to high blood pressure, high cholesterol, smoking, diabetes, and obesity. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2020, 4.6% adults were diagnosed with coronary heart disease. Thus, to prevent these cardiovascular diseases, imaging procedure is preferred using imaging agents.
Browse detailed statistical insights from the report, “North America Imaging Agents Market Forecast 2028 By Application (Oncology, Gastrointestinal, Cardiology Neurology), Product Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Modality (X-Ray, Computed Tomography [CT], Magnetic Resonance Imaging [MRI], Ultrasound), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic & Imaging Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
The X-ray segment will witness 4.7% CAGR through 2028, attributed to increasing diagnosis methods and treatment for various diseases in a quick and efficient manner. X-rays are considered as a valuable medical tool for a wide variety of examinations and procedures. Moreover, rising use of X-ray imaging for the detection of COVID-19-related lesions in the lungs for disease management is expected to drive the market growth.
The hospital segment held over 40% market share in 2021, due to the increasing number of hospitals and skilled professionals. Growing adoption of advanced diagnostic methods and technologies will propel the segmental growth as this further leads to surging number of MRI, ultrasound, and CT scans. Therefore, government has increased healthcare investments leading positive impact on the market revenue.
The Canada imaging agent industry will experience 6.5% growth rate during the forecast period, credited to increasing number of cancer cases will positively promote country’s market progress. Also, wide availability of advanced IT-enabled solutions to analyze workflow efficiencies, patient safety and imaging optimization will benefit country-level growth. Similarly, rising prevalence of cancer, epilepsy, Alzheimer's disease, and orthopedic diseases is anticipated to drive the market demand.
The North American imaging agent market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:
North America Market, By Product Type
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
- Barium-based Contrast Media
North America Market, By Application
North America Market, By Modality
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
North America Market, By End-use
- Ambulatory Surgical Centers
- Diagnostic & Imaging Centers
The above information has been provided for the following countries: